Cephalosporin Clinical Applications

Introduction to Cephalosporin Generations

The American College of Cardiology is not mentioned, however, Clinical Microbiology and Infection guidelines recommend first-generation cephalosporins, such as cephalexin, for skin and soft tissue infections (mild cases) 1
The Journal of Urology suggests that cefazolin (IV) is an example of a first-generation cephalosporin 2
Clinical Microbiology and Infection guidelines recommend first-generation cephalosporins as first-line treatment for uncomplicated skin and soft tissue infections 1
Clinical Microbiology and Infection guidelines suggest that first-generation cephalosporins are used for surgical prophylaxis, particularly for cardiac surgery 3

Diabetes/Metabolism Research and Reviews state that second-generation cephalosporins are used for moderate to severe community-acquired infections 4
Journal of Allergy and Clinical Immunology guidelines recommend second-generation cephalosporins, such as cefuroxime, for respiratory tract infections 5
The Journal of Urology suggests that second-generation cephalosporins are used for surgical prophylaxis for procedures with risk of anaerobic contamination 2
Journal of Allergy and Clinical Immunology guidelines state that cefuroxime has better activity against β-lactamase-producing H. influenzae and M. catarrhalis compared to first-generation agents 5
Diabetes/Metabolism Research and Reviews recommend third-generation cephalosporins for serious gram-negative infections 4
Journal of Allergy and Clinical Immunology guidelines suggest that third-generation cephalosporins, such as cefpodoxime and cefdinir, are suitable agents for respiratory infections 5
Clinical Microbiology and Infection guidelines recommend fifth-generation cephalosporins, such as ceftaroline, for complicated skin and soft tissue infections, including those caused by MRSA 6

Clinical Microbiology and Infection guidelines suggest that first-generation cephalosporins remain the standard for most clean procedures 3
The Journal of Urology recommends that for procedures with risk of anaerobic contamination, second-generation agents or combination therapy may be preferred 2
Clinical Microbiology and Infection guidelines state that for skin and soft tissue infections, first-line options for mild infections include cefalexin, cloxacillin, or amoxicillin-clavulanic acid 1
Clinical Microbiology and Infection guidelines recommend that for MRSA infections, consider alternative agents like vancomycin, linezolid, or trimethoprim-sulfamethoxazole 6

Journal of Allergy and Clinical Immunology guidelines suggest that second or third-generation cephalosporins are preferred due to better coverage of respiratory pathogens 5
Journal of Allergy and Clinical Immunology guidelines recommend that cefpodoxime and cefdinir are suitable agents for respiratory infections 5

The American College of Clinical Microbiology and Infection recommends against using third-generation cephalosporins as first-line agents for mild to moderate skin and soft tissue infections, instead suggesting first-generation cephalosporins like cefalexin or cloxacillin 7, 8

For necrotizing fasciitis, the Infectious Diseases Society of America recommends ceftriaxone (2g IV daily) plus metronidazole, with or without vancomycin depending on MRSA risk 7, 8
This combination provides coverage against streptococci, staphylococci, gram-negative organisms, and anaerobes, as suggested by the Clinical Infectious Diseases guidelines 9
Second- and third-generation cephalosporins (cefuroxime, ceftriaxone, cefotaxime) are acceptable alternatives for severe animal bite infections when given intravenously, according to the Clinical Microbiology and Infection guidelines 7
These should be combined with appropriate anaerobic coverage, as recommended by the Clinical Microbiology and Infection guidelines 7
Third-generation cephalosporins (ceftriaxone, cefotaxime) combined with clindamycin or metronidazole may be used for complicated skin infections in immunocompromised hosts, as suggested by the Clinical Microbiology and Infection and Clinical Infectious Diseases guidelines 10, 9

The 2024 WHO guidelines and IDSA guidelines explicitly recommend against third-generation cephalosporins for uncomplicated skin infections, due to their reduced activity against gram-positive organisms and the risk of promoting resistance 7, 8
First-generation cephalosporins (cefalexin, cefazolin) are superior for routine staphylococcal and streptococcal skin infections, as they have a narrower spectrum and are more cost-effective 7, 10
Meta-analyses show no difference in treatment effect between different generations of cephalosporins for cellulitis (RR 1.00; 95% CI 0.94-1.06), according to the Clinical Microbiology and Infection guidelines 7

Ceftriaxone has no activity against MRSA, and vancomycin, linezolid, or daptomycin should be added if MRSA is suspected, as recommended by the Clinical Microbiology and Infection and Clinical Infectious Diseases guidelines 7, 9
Ceftriaxone has no antipseudomonal activity, and ceftazidime or cefoperazone are required for Pseudomonas coverage 9